Nodular tumours of the liver are induced by LPA signalling, and this could be driven, at least in part, by LPA binding to LPAR2, which activates p38 signalling to promote abnormal leptin expression and liver carcinogenesis [97]. This evidence concerns the gene LPAR2 and neoplasm.